Medtronic plc MDT Income Statement

Medtronic plc (MDT)

Income statement / Quarterly

Jan'20	Oct'19	Jul'19	Apr'19	Jan'19	Oct'18	Jul'18	Apr'18	Jan'18	Oct'17	Jul'17	Apr'17	Jan'17	Oct'16	Jul'16	Apr'16	Jan'16	Oct'15	Jul'15	Apr'15	Jan'15	Oct'14	Jul'14
Net sales
7,717	7,706	7,493	8,146	7,546	7,481	7,384	8,144	7,369	7,050	7,390	7,916	7,283	7,345	7,166	7,567	6,934	7,058	7,274	7,304	4,318	4,366	4,273
Costs and expenses:
Cost of products sold
2,400	2,394	2,366	2,483	2,265	2,203	2,204	2,398	2,194	2,123	2,352	2,439	2,268	2,326	2,261	2,363	2,141	2,182	2,456	2,934	1,128	1,142	1,105
Research and development expense
573	603	587	594	561	590	585	592	559	556	549	553	530	554	556	575	546	545	558	528	373	374	365
Selling, general, and administrative expense
2,587	2,620	2,543	2,620	2,596	2,605	2,597	2,596	2,523	2,539	2,580	2,786	2,388	2,416	2,428	2,360	2,317	2,343	2,449	2,404	1,487	1,507	1,506
Amortization of intangible assets
436	441	440	437	436	445	446	448	461	460	454	496	497	500	487	483	484	483	481	468	89	89	87
Restructuring charges, net
13	27	47	86	26	24	62	7	7	8	8	141	21	47	94	131	19	73	67	207	0	0	30
Acquisition-related items
-	-	-	-	-	-	-	-	-	-	-	-	68	28	52	100	63	49	71	368	80	61	41
Certain litigation charges
108	121	47	0	63	0	103	0	61	0	0	0	218	0	82	0	0	26	0	-	0	0	-
Divestiture-related items
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Gain on sale of businesses
-	-	-	-	-	-	-	-	0	697	-	-	0	0	-	-	-	-	-	-	-	-	-
Other operating (income) expense, net
39	-149	22	20	-57	-70	-151	-175	-128	-167	-65	-	-	-	-	-	-	-	-	-	-	-	-
Special charge
-	-	-	-	-	-	-	-	-	-	-	-	100	0	-	-	0	-	-	-	-138	100	-
Other expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-46	-89	-39	20	-9	-57	-61	20	-24	-63	-51
Operating profit (loss)
1,639	1,351	1,485	1,946	1,542	1,544	1,236	1,928	1,436	1,894	1,382	1,684	1,147	1,385	1,167	1,575	1,355	1,300	1,131	373	1,275	1,030	1,088
Other non-operating income, net
96	108	101	64	71	52	186	114	-139	107	99	-	-	-	-	-	-	-	-	-	-	-	-
Investment loss
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	88	91	93	110	99	107	115	113	95	86	92
Interest expense
156	165	609	718	243	241	242	317	270	273	286	290	268	264	272	481	275	324	306	299	176	94	97
Interest expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-180	-173	-179	-371	-176	-217	-191	-186	-81	-8	-5
Income (loss) before income taxes
1,579	1,294	977	1,292	1,370	1,355	1,180	1,725	1,027	1,728	1,195	1,435	967	1,212	988	1,134	1,179	1,083	940	187	1,194	1,022	1,083
Income tax provision
-340	-77	100	110	99	235	103	260	2,419	-285	186	271	147	101	59	31	84	563	120	188	217	194	212
Net income (loss)
1,919	1,371	877	1,182	1,271	1,120	1,077	1,465	-1,392	2,013	1,009	1,164	820	1,111	929	-	1,095	520	-	-	-	-	-
Net income attributable to noncontrolling interests
4	7	13	10	2	5	2	5	-3	-4	-7	1	-1	-4	0	-	0	0	-	-	-	-	-
Net income (loss) attributable to Medtronic
1,915	1,364	864	1,172	1,269	1,115	1,075	1,460	-1,389	2,017	1,016	1,163	821	1,115	929	1,103	1,095	520	820	-1	977	828	871
Basic earnings per share (usd per share)
1.43	1.02	0.64	0.87	0.95	0.83	0.79	1.08	-1.03	1.49	0.75	0.84	0.60	0.81	0.67	0.78	0.78	0.37	0.58	-0.27	0.99	0.84	0.88
Diluted earnings per share (usd per share)
1.42	1.01	0.64	0.86	0.94	0.82	0.79	1.08	-1.03	1.48	0.74	0.84	0.59	0.80	0.66	0.78	0.77	0.36	0.57	-0.27	0.98	0.83	0.87
Basic weighted average shares outstanding (shares)
1,340	1,340	1,340	1,340	1,342	1,349	1,352	1,355	1,354	1,355	1,361	1,371	1,372	1,380	1,392	1,400	1,406	1,412	1,418	1,423	983	981	992
Diluted weighted average shares outstanding (shares)
1,351	1,351	1,351	1,351	1,352	1,360	1,365	1,377	1,354	1,365	1,375	1,382	1,383	1,392	1,407	1,416	1,422	1,428	1,436	1,442	995	993	1,005
Cash dividends declared per ordinary share (usd per share)
-	-	-	-	-	-	-	-	-	-	0.46	-	0.43	0.43	0.43	0.38	0.38	0.38	0.38	0.30	0.30	0.30	0.30